To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CBX2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
134 supporting clones for gene CBX2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB452048.
matches multiple genes
testis .a 1 to 496 1 to 496   tiling clone, also hits gene rasmar 496/496
(100 %)
3 diff
(99.4 %id)
CN367085 embryonic stem cells, cell lines H1, H7, andH9 .a 46 to 543 1 to 498       498/498
(100 %)
3 diff
(99.4 %id)
NM_005189.2   .a 47 to 4311 1 to 4265   RefSeq,   4265/4265
(100 %)
0 diff
(100 %id)
CN367087 embryonic stem cells, cell lines H1, H7, andH9 .a 123 to 764 1 to 643       643/643
(100 %)
1 diff
(99.9 %id)
CV815254 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 145 to 921 1 to 776       776/776
(100 %)
9 diff
(98.9 %id)
CN367091 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 250 to 973 1 to 727       727/727
(100 %)
4 diff
(99.5 %id)
BE781770 eye, retinoblastoma .a 304 to 1048 1 to 738       738/1008
(73 %)
25 diff
(97.6 %id)
AL521369 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 393 to 1260 1 to 863   tiling clone,   863/866
(99 %)
6 diff
(99.4 %id)
BX344772 Neuroblastoma Cot 10-normalized .a 393 to 1207 1 to 813       813/813
(100 %)
39 diff
(95.3 %id)
CN367094 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 466 to 1043 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
BQ224718 melanotic melanoma, skin .a 480 to 1285 1 to 817       817/899
(90 %)
20 diff
(97.8 %id)
CN367089 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 524 to 1098 1 to 574       574/574
(100 %)
3 diff
(99.5 %id)
CN367095 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 524 to 699 1 to 176       176/176
(100 %)
0 diff
(100 %id)
CN367098 embryonic stem cells, cell lines H1, H7, andH9 .a 633 to 1206 1 to 576       576/578
(99 %)
4 diff
(99.4 %id)
CN367088 embryonic stem cells, cell lines H1, H7, andH9 .a 835 to 1417 1 to 585       585/585
(100 %)
6 diff
(99.0 %id)
CF136474 lymph .a 885 to 1217 1 to 333       333/333
(100 %)
6 diff
(98.2 %id)
CN367097 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1024 to 1621 1 to 598   tiling clone,   598/598
(100 %)
1 diff
(99.9 %id)
BX389354 Neuroblastoma Cot 10-normalized .a 1172 to 1997 1 to 833       833/863
(96 %)
27 diff
(96.9 %id)
AI554178 pooled .a 1237 to 1645 470 to 65   tiling clone,   406/475
(85 %)
0 diff
(100 %id)
CN367086 embryonic stem cells, cell lines H1, H7, andH9 .a 1318 to 1503 1 to 186       186/186
(100 %)
0 diff
(100 %id)
BE258133 eye, retinoblastoma .a 1349 to 2032 1 to 685       685/723
(94 %)
22 diff
(97.0 %id)
BM803925 leiomyosarcoma, uterus .a 1366 to 1868 1 to 516       516/1106
(46 %)
17 diff
(98.5 %id)
CN367096 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1369 to 1964 1 to 595       595/595
(100 %)
2 diff
(99.7 %id)
BX280266 leiomyosarcoma, uterus .a 1465 to 1934 1 to 470       470/470
(100 %)
1 diff
(99.8 %id)
BM460034 leiomyosarcoma, uterus .a 1465 to 2185 1 to 725       725/1138
(63 %)
29 diff
(97.5 %id)
CN367093 embryonic stem cells, cell lines H1, H7, andH9 .a 1476 to 1801 1 to 326       326/326
(100 %)
1 diff
(99.7 %id)
CB053187 leiomyosarcoma, soft tissue .a 1491 to 1615 1 to 125       125/125
(100 %)
0 diff
(100 %id)
DA537423 Kidney .a 1501 to 2047 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
BQ069799 brain, neuroblastoma, cell line .a 1577 to 2390 1 to 831   tiling clone,   831/1073
(77 %)
33 diff
(97.0 %id)
CN367092 embryonic stem cells, DMSO-treated H9 cellline .a 1699 to 2402 1 to 705       705/705
(100 %)
3 diff
(99.6 %id)
CN367090 embryonic stem cells, cell lines H1, H7, andH9 .a 1708 to 2325 1 to 619       619/622
(99 %)
3 diff
(99.6 %id)
BG354579   .a 1847 to 4240 1 to 2398       2398/2398
(100 %)
5 diff
(99.8 %id)
CX751282 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1969 to 2639 1 to 670   tiling clone, Submitted on the opposite strand 670/707
(94 %)
29 diff
(95.9 %id)
BG395186 eye, retinoblastoma .a 2034 to 2461 1 to 428       428/428
(100 %)
3 diff
(99.3 %id)
BE539976 cervix .a 2041 to 2561 1 to 549       549/566
(96 %)
36 diff
(93.7 %id)
DA540258 lung .a 2046 to 2586 2 to 542   capped   541/541
(100 %)
2 diff
(99.7 %id)
CF141839 CNCAP(3)T-225 cell line, Prostate .a 2048 to 2579 1 to 532       532/532
(100 %)
7 diff
(98.7 %id)
TI_154172663   .a 2055 to 2652 81 to 677       597/598
(99 %)
6 diff
(99.0 %id)
BQ082264 Ascites, stomach .a 2121 to 2359 1 to 239       239/239
(100 %)
3 diff
(98.8 %id)
BI196196 brain, neuroblastoma .a 2199 to 3089 1 to 884       884/918
(96 %)
32 diff
(96.6 %id)
BU845448 ovary, teratocarcinoma, cell line .a 2269 to 3195 1 to 933       933/939
(99 %)
11 diff
(98.9 %id)
BM557891 duodenal adenocarcinoma, cell line, small intestine .a 2281 to 2904 1 to 630       630/1070
(58 %)
5 diff
(99.6 %id)
AL157459 testis .a 2291 to 4642 14 to 2365   tiling clone, available from DKFZ, AAA   2352/2365
(99 %)
6 diff
(99.8 %id)
BE799034 lung, small cell carcinoma .a 2295 to 2651 460 to 809       759/1025
(74 %)
12 diff
(98.9 %id)
BE793695 lung, small cell carcinoma .a 2304 to 2919 1 to 622       622/624
(99 %)
10 diff
(98.4 %id)
DA713236   .a 2332 to 2887 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
CN358716 embryonic stem cells, cell lines H1, H7, andH9 .a 2333 to 2989 12 to 669       658/674
(97 %)
2 diff
(99.8 %id)
BF307016 muscle, rhabdomyosarcoma .a 2339 to 3164 1 to 817       817/1097
(74 %)
33 diff
(97.0 %id)
BQ881757 dorsal root ganglia .a 2368 to 3295 1 to 940   tiling clone,   940/941
(99 %)
22 diff
(97.7 %id)
AA356375   .a 2486 to 2755 1 to 270       270/270
(100 %)
1 diff
(99.7 %id)
BX328913 Neuroblastoma Cot 10-normalized .a 2512 to 3439 929 to 8       922/929
(99 %)
0 diff
(100 %id)
BX328914 Neuroblastoma Cot 10-normalized .a 2549 to 3432 904 to 15       890/932
(95 %)
0 diff
(100 %id)
BQ422469 embryonal carcinoma, cell line, testis .a 2597 to 3313 1 to 731       731/906
(80 %)
33 diff
(96.4 %id)
DA949875 Spleen .a 2614 to 3175 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
CN358715 embryonic stem cells, DMSO-treated H9 cellline .a 2659 to 2993 9 to 343       335/343
(97 %)
6 diff
(98.3 %id)
BE797673 lung, small cell carcinoma .a 2719 to 3400 38 to 719       682/720
(94 %)
4 diff
(99.5 %id)
BI543223 brain .a 2810 to 2991 22 to 202       181/202
(89 %)
6 diff
(97.1 %id)
DN601768 human embryonic stem cells .a 2894 to 3472 1 to 579       579/579
(100 %)
3 diff
(99.5 %id)
CF242799 Brain glioblastoma .a 2942 to 3813 1 to 881       881/882
(99 %)
16 diff
(98.2 %id)
BG979687 colon_normal .a 2951 to 3235 1 to 277       277/289
(95 %)
7 diff
(97.6 %id)
BE799000 lung, small cell carcinoma .a 3008 to 3704 40 to 748       709/936
(75 %)
14 diff
(98.6 %id)
AI611640 pooled germ cell tumors .a 3042 to 3293 279 to 28   AAA   252/252
(100 %)
4 diff
(98.5 %id)
BQ428097 leiomyosarcoma, uterus .a 3071 to 3912 1 to 859       859/908
(94 %)
26 diff
(97.2 %id)
TI_57188639   .a 3071 to 3869 52 to 867       816/854
(95 %)
35 diff
(96.0 %id)
BI856683 breast, mammary adenocarcinoma, cell line .a 3072 to 3869 1 to 815       815/853
(95 %)
34 diff
(96.1 %id)
BM839724 stomach .a 3110 to 3452 1 to 343       343/343
(100 %)
0 diff
(100 %id)
BM831545 stomach .a 3110 to 3731 1 to 622       622/622
(100 %)
0 diff
(100 %id)
AA378873 synovial membrane .a 3168 to 3445 1 to 278       278/278
(100 %)
0 diff
(100 %id)
BM717764 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 3232 to 3645 1 to 414   fully sequenced,   414/414
(100 %)
0 diff
(100 %id)
AL521368 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 3280 to 4202 927 to 5       923/927
(99 %)
0 diff
(100 %id)
TI_149310026   .a 3285 to 4230 1024 to 95   AAA   930/975
(95 %)
19 diff
(98.1 %id)
AA353888   .a 3312 to 3638 1 to 327       327/327
(100 %)
2 diff
(99.4 %id)
CB410567.
matches multiple genes
maxilla, pooled .a 3392 to 3958 1 to 567     also hits gene forgly 567/567
(100 %)
0 diff
(100 %id)
BE885109 leiomyosarcoma, uterus .a 3411 to 4168 1 to 744       744/951
(78 %)
34 diff
(96.5 %id)
AW796707 uterus .a 3487 to 3701 1 to 216       216/216
(100 %)
4 diff
(98.2 %id)
BE267375 lung, small cell carcinoma .a 3507 to 4206 1 to 696       696/713
(97 %)
13 diff
(98.2 %id)
BQ083206 Ascites, stomach .a 3521 to 3711 1 to 190       190/190
(100 %)
3 diff
(98.5 %id)
BU688372 lung .a 3560 to 4230 688 to 19   AAA   670/670
(100 %)
1 diff
(99.9 %id)
BU630695 cell lines, Chondrosarcoma .a 3561 to 4230 686 to 19   AAA   668/668
(100 %)
2 diff
(99.8 %id)
BE514414 Burkitt lymphoma, lymph .a 3566 to 4222 31 to 685       655/743
(88 %)
3 diff
(99.6 %id)
BM679787 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 3615 to 4229 633 to 19   fully sequenced, AAA   615/615
(100 %)
0 diff
(100 %id)
BM723186 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 3657 to 4231 1 to 575       575/579
(99 %)
1 diff
(99.9 %id)
BE138625 invasive adenocarcinoma, lung .a 3699 to 4101 1 to 402     Submitted on the opposite strand 402/402
(100 %)
6 diff
(98.6 %id)
AI885164 anaplastic oligodendroglioma, brain .a 3719 to 4224 506 to 1       506/506
(100 %)
0 diff
(100 %id)
AW071865 anaplastic oligodendroglioma, brain .a 3720 to 4231 514 to 3       512/514
(99 %)
0 diff
(100 %id)
CB053186 leiomyosarcoma, soft tissue .a 3760 to 4224 490 to 26   AAA   465/465
(100 %)
1 diff
(99.8 %id)
AA502767 colon .a 3763 to 4225 466 to 3       464/466
(99 %)
0 diff
(100 %id)
AI417551 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3775 to 4224 462 to 13   AAA   450/450
(100 %)
0 diff
(100 %id)
AW007061 anaplastic oligodendroglioma, brain .a 3778 to 4230 453 to 1       453/453
(100 %)
2 diff
(99.6 %id)
AI890632 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3784 to 4241 465 to 7       459/465
(98 %)
0 diff
(100 %id)
BM988729 lung, Lung Focal Fibrosis .a 3796 to 4221 444 to 19   AAA   426/426
(100 %)
0 diff
(100 %id)
AI338589   .a 3797 to 4230 449 to 16   AAA   434/434
(100 %)
2 diff
(99.6 %id)
AW771437 colon, juvenile granulosa tumor .a 3801 to 4241 449 to 9       441/449
(98 %)
0 diff
(100 %id)
BX110913 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3804 to 4240 451 to 15   AAA   437/437
(100 %)
0 diff
(100 %id)
BF513841   .a 3817 to 4240 441 to 18   AAA   424/424
(100 %)
0 diff
(100 %id)
AI361622 anaplastic oligodendroglioma, brain .a 3834 to 4240 407 to 1       407/407
(100 %)
0 diff
(100 %id)
AI874296 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3834 to 4221 390 to 3       388/390
(99 %)
0 diff
(100 %id)
AW197075 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 3837 to 4229 393 to 1       393/393
(100 %)
0 diff
(100 %id)
AA581572 bulk alveolar tumor .a 3839 to 4240 414 to 12   AAA   403/403
(100 %)
14 diff
(96.6 %id)
BE501040 pooled germ cell tumors .a 3848 to 4231 385 to 2       384/385
(99 %)
0 diff
(100 %id)
AI589838 anaplastic oligodendroglioma, brain .a 3873 to 4240 405 to 38   AAA   368/368
(100 %)
18 diff
(95.2 %id)
BF510073   .a 3878 to 4230 370 to 18   AAA   353/353
(100 %)
0 diff
(100 %id)
BF223480 pooled germ cell tumors .a 3878 to 4241 371 to 5       367/371
(98 %)
0 diff
(100 %id)
AA779456   .a 3884 to 4229 372 to 27       346/372
(93 %)
0 diff
(100 %id)
AA347010 heart .a 3894 to 4223 1 to 330       330/330
(100 %)
0 diff
(100 %id)
AI680512 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 3897 to 4224 328 to 1       328/328
(100 %)
0 diff
(100 %id)
CN358713 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3914 to 4311 1 to 398       398/398
(100 %)
3 diff
(99.3 %id)
BU602092 mixed (pool of 40 RNAs) .a 3917 to 4239 1 to 323       323/323
(100 %)
2 diff
(99.4 %id)
AI650610 pooled germ cell tumors .a 3929 to 4231 308 to 6       303/308
(98 %)
0 diff
(100 %id)
AW196779 pooled germ cell tumors .a 3929 to 4231 308 to 6       303/308
(98 %)
0 diff
(100 %id)
BQ021972 placenta .a 3931 to 4228 315 to 18   AAA   298/298
(100 %)
3 diff
(99.0 %id)
AA010188 liver and spleen .a 3940 to 4241 315 to 4       312/359
(86 %)
0 diff
(100 %id)
DW439965 Liver .a 3944 to 4167 17 to 240       224/240
(93 %)
9 diff
(96.3 %id)
AI918191 anaplastic oligodendroglioma, brain .a 3989 to 4231 244 to 2       243/244
(99 %)
0 diff
(100 %id)
AI018374   .a 3999 to 4225 231 to 5       227/231
(98 %)
0 diff
(100 %id)
BM988770 lung, Lung Focal Fibrosis .a 4072 to 4229 176 to 19   AAA   158/158
(100 %)
2 diff
(98.8 %id)
NM_032647.3   .b 1 to 1077 1 to 1077 exact RefSeq,   1077/1077
(100 %)
0 diff
(100 %id)
BC004252 Uterus, endometrium adenocarcinoma .b 17 to 1077 1 to 1061   tiling clone, available from MGC,   1061/1131
(93 %)
1 diff
(100.0 %id)
BC119759 PCR rescued clones .b 30 to 779 1 to 750       750/750
(100 %)
0 diff
(100 %id)
BC119760 PCR rescued clones .b 30 to 779 1 to 750       750/750
(100 %)
0 diff
(100 %id)
BE393424 endometrium, adenocarcinoma cell line, uterus .b 36 to 529 1 to 494   available from MGC,   494/494
(100 %)
0 diff
(100 %id)
TI_1948099740   .b 57 to 271 136 to 350   fully sequenced,   215/241
(89 %)
6 diff
(97.6 %id)
TI_1948099910   .b 57 to 271 130 to 344   fully sequenced,   215/241
(89 %)
6 diff
(97.6 %id)
TI_1948100087   .b 57 to 271 137 to 351   fully sequenced,   215/241
(89 %)
6 diff
(97.6 %id)
TI_1948100258   .b 57 to 404 135 to 482   fully sequenced,   348/374
(93 %)
6 diff
(98.4 %id)
CV026366 mixed .b 59 to 693 1 to 635       635/655
(96 %)
2 diff
(99.7 %id)
TI_1948099741   .b 210 to 691 615 to 134   fully sequenced,   482/615
(78 %)
0 diff
(100 %id)
TI_1948099911   .b 210 to 693 613 to 129   fully sequenced,   485/613
(79 %)
0 diff
(100 %id)
TI_1948100088   .b 210 to 693 612 to 129   fully sequenced,   484/612
(79 %)
0 diff
(100 %id)
TI_1948100259   .b 374 to 697 452 to 121   fully sequenced,   332/452
(73 %)
7 diff
(98.5 %id)
AX721084   .c 1 to 561 1 to 561   tiling clone,   561/561
(100 %)
2 diff
(99.7 %id)
AX721090   .c 1 to 567 1 to 569 G45V E46G G47R G49W E50G ... tiling clone,   569/571
(99 %)
3 diff
(99.5 %id)
AA578671 colon, tumor .c 107 to 536 429 to 1       429/429
(100 %)
3 diff
(99.4 %id)
AW769671 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c 200 to 567 374 to 2       373/379
(98 %)
0 diff
(100 %id)
AW769665 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c 236 to 567 336 to 2       335/336
(99 %)
0 diff
(100 %id)
AI559353 anaplastic oligodendroglioma, brain .c 331 to 567 239 to 3       237/239
(99 %)
0 diff
(100 %id)
AA477180 ovarian tumor, ovary Gene CBX2, variant not shown         This clone was ignored    
AA479787 ovarian tumor, ovary Gene CBX2, variant not shown         This clone was ignored    
BE313493 brain, neuroblastoma Gene CBX2, variant not shown         Suspected internal deletion, this clone was ignored    
BF311668 brain, neuroblastoma Gene CBX2, variant not shown         Suspected internal deletion, this clone was ignored    
BM473885 eye, retinoblastoma Gene CBX2, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI